Transnasal Humidified Rapid Insufflation Ventilatory Exchange in children requiring emergent intubation (Kids THRIVE): a protocol for a randomised controlled trial by George, Shane et al.
1George S, et al. BMJ Open 2019;9:e025997. doi:10.1136/bmjopen-2018-025997
Open access 
Transnasal Humidified Rapid 
Insufflation Ventilatory Exchange in 
children requiring emergent intubation 
(Kids THRIVE): a protocol for a 
randomised controlled trial
Shane George,  1,2,3,4,5 Susan Humphreys,3 Tara Williams,3 Ben Gelbart,6,7 
Arjun Chavan,8 Katie Rasmussen,9,10 Anusha Ganeshalingham,11 Simon Erickson,12 
Subodh Suhas Ganu,13 Nitesh Singhal,14 Kelly Foster,4,10 Brenda Gannon,15 
Kristen Gibbons,3 Luregn J Schlapbach,  3 Marino Festa,5,14 Stuart Dalziel,4,11,16 
Andreas Schibler,3,5 on behalf of the Paediatric Critical Care Research Group 
(PCCRG), Paediatric Research in Emergency Departments International 
Collaborative (PREDICT) and the Australia and New Zealand Intensive Care Society 
Paediatric Study Group (ANZICS PSG)
To cite: George S, 
Humphreys S, Williams T, et al.  
Transnasal Humidified Rapid 
Insufflation Ventilatory Exchange 
in children requiring emergent 
intubation (Kids THRIVE): a 
protocol for a randomised 
controlled trial. BMJ Open 
2019;9:e025997. doi:10.1136/
bmjopen-2018-025997
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
025997).
Received 13 August 2018
Revised 29 November 2018
Accepted 4 January 2019
For numbered affiliations see 
end of article.
Correspondence to
Dr Shane George;  
 shane. george@ uq. edu. au
Protocol
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Introduction Emergency intubation of children with 
abnormal respiratory or cardiac physiology is a high-
risk procedure and associated with a high incidence 
of adverse events including hypoxemia. Successful 
emergency intubation is dependent on inter-related 
patient and operator factors. Preoxygenation has been 
used to maximise oxygen reserves in the patient and 
to prolong the safe apnoeic time during the intubation 
phase. Transnasal Humidified Rapid Insufflation Ventilatory 
Exchange (THRIVE) prolongs the safe apnoeic window 
for a safe intubation during elective intubation. We 
designed a clinical trial to test the hypothesis that THRIVE 
reduces the frequency of adverse and hypoxemic events 
during emergency intubation in children and to test the 
hypothesis that this treatment is cost-effective compared 
with standard care.
Methods and analysis The Kids THRIVE trial is a 
multicentre randomised controlled trial performed in 
participating emergency departments and paediatric 
intensive care units. 960 infants and children aged 0–16 
years requiring emergency intubation for all reasons will 
be enrolled and allocated to THRIVE or control in a 1:1 
allocation with stratification by site, age (<1, 1–7 and >7 
years) and operator (junior and senior). Children allocated 
to THRIVE will receive weight appropriate transnasal 
flow rates with 100% oxygen, whereas children in the 
control arm will not receive any transnasal oxygen 
insufflation. The primary outcomes are defined as follows: 
(1) hypoxemic event during the intubation phase defined 
as SpO
2 <90% (patient-dependent variable) and (2) first 
intubation attempt success without hypoxemia (operator-
dependent variable). Analyses will be conducted on an 
intention-to-treat basis.
Ethics and dissemination Ethics approval for the 
protocol and consent process has been obtained 
(HREC/16/QRCH/81). The trial has been actively recruiting 
since May 2017. The study findings will be submitted for 
publication in a peer-reviewed journal.
trial registration number ACTRN12617000147381.
bACkground
Emergency intubation of the trachea in 
critically ill children represents one of the 
most challenging procedures that a clinician 
strengths and limitations of this study
 ► This is the first study investigating the use of 
Transnasal   H umidified  R apid Insufflation V enti-
latory  E xchange in paediatric patients in the emer-
gency and intensive care setting.
 ► Data collected during a stressful and often un-
planned procedure are validated against a video re-
cording to ensure data accuracy and fidelity. Where 
there is a discrepancy between the two values, video 
data will be used for analysis.
 ► Apart from the application of apnoeic oxygenation, 
all other aspects of the intubation process remain 
at clinician preference, ensuring that bias and con-
founding are minimised and any observed effect 
can be more reliably attributed to the intervention 
applied.
 ► Blinding of the intervention is not possible due to 
visual differences in the intervention arm.
 ► Seniority and experience of the intubating clinician 
may influence the likelihood of intubation success. 
To limit this potential confounder, there is a strati-
fication into junior and senior operators with a pre-
planned subgroup analysis.
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working with acutely ill children performs. The intuba-
tion of children with unstable physiology in the emer-
gency department (ED) or intensive care unit (ICU) is 
associated with a high rate (up to 40%) of life-threat-
ening adverse events (AEs).1 Successful emergency intu-
bation is dependent on inter-related patient and operator 
factors. While a large body of literature defines optimal 
practice in intubation and difficult airway management 
in controlled theatre settings, emergency intubations in 
critically ill children are characterised by a deteriorating, 
unstable patient, sometimes with features of a difficult 
airway, yet are predominantly managed by ED and ICU 
teams rather than anaesthetists.
The incidence of paediatric emergency intubations is 
relatively low even in high-volume tertiary paediatric EDs, 
resulting in infrequent exposure of medical staff to this 
vital and time-critical procedure and limited practical 
experience in comparison to anaesthetists in an oper-
ating theatre setting. These challenges are even greater 
in regional and district hospitals, where paediatric emer-
gency intubations represent relatively rare events. There-
fore, techniques to optimise intubation conditions and 
improve patient-related and operator-dependent factors 
are essential to increase the safety of emergency paedi-
atric intubations in all settings.2
The most critical phase of intubation is the period when 
clinicians attempt to secure the airway with an endotra-
cheal tube (ETT); during this phase, the child is apnoeic 
and residual oxygen capacity of the lung is being depleted. 
To improve child-related factors, preoxygenation prior to 
induction of anaesthesia has been described since 1955 as 
a mechanism for maximising oxygen reserves and there-
fore prolonging the safe apnoeic time available for intuba-
tion particularly in emergency and difficult intubations.3 
Infants and children have, in comparison to adults, a much 
lower tolerance for emergency intubation.4 As a result, 
they are more likely to experience alveolar de-recruit-
ment and significant oxygen desaturation. Recent studies 
have shown that any failed attempt of emergency intuba-
tion is associated with a prolonged need for mechanical 
ventilation in intensive care.5 6 Preoxygenation does not 
supply an ongoing gas exchange and therefore there is 
an urgent need for newer methods to continue improved 
oxygenation during the apnoeic phase.
We have recently shown that the safe apnoeic time in 
healthy infants and children undergoing elective intuba-
tion can be substantially extended with a new technique, 
called Transnasal Humidified Rapid Insufflation Ventila-
tory Exchange (THRIVE).7 THRIVE provides high-flow 
humidified oxygen through nasal cannulae and allows 
continued peri-laryngoscopy oxygen delivery during 
apnoea. The benefit of THRIVE in allowing more time 
for safe intubation is thus likely beneficial in those diffi-
cult anatomical airways and cardiorespiratory compro-
mise during emergency intubation. There are currently 
no published randomised studies investigating the use 
of THRIVE or other forms of apnoeic oxygenation in 
emergency intubation in children. In the adult literature, 
there have been a number of systematic reviews and 
meta-analyses on the topic of apnoeic oxygenation.8–13 
In these reviews, there is significant heterogeneity in the 
studies included, and a paucity of adequately powered 
randomised trials. Overall, in adults there is a reduced 
frequency of oxygen desaturation when apnoeic oxygen-
ation is used during intubation; however, this effect 
has not been demonstrated in patients with respiratory 
failure.
In order to improve emergency intubation conditions in 
children, our aim is to investigate the efficacy of THRIVE 
in critically ill children aged between 0 and 16 years in 
a large multicentre trial. We hypothesise that THRIVE 
reduces the frequency of life-threatening oxygen desat-
uration and increases frequency of first attempt success 
without hypoxemia in emergent intubation of children 
compared with standard practice. We also aim to demon-
strate that this leads to a reduced proportion of AEs and 
reduced length of mechanical ventilation or length of stay 
in intensive care. This project will assess health economic 
impacts and cost-effectiveness of the intervention, taking 
into account the heterogeneity of service users, health 
system, geographical and economic conditions and end 
implications for resource allocation from the payer’s 
perspective.
MEthods
study design and setting
This study is a multicentre, non-blinded, randomised 
controlled trial evaluating the efficacy of THRIVE used 
for apnoeic oxygenation during emergency intubation of 
children aged 0–16 years. The study will be conducted in 
the EDs and paediatric intensive care units (PICUs) of 
participating hospitals.
Participants
Infants and children will be identified and recruited by 
treating clinicians in the ED and PICU of the partici-
pating hospitals. All patients being intubated in these 
locations will be screened for inclusion in the study. 
Patients meeting all inclusion criteria and no exclusion 
criteria (table 1) are eligible for randomisation.
In all participating centres, prospective consent will be 
obtained from the parent or guardian where possible. 
When prospective consent is not possible or practical, and 
local legislation allows, patients will be randomised to the 
study and written informed consent to remain in the study 
will be sought from parents and guardians at the earliest 
possible time after emergency stabilisation of the child 
(consent-to-continue). Data for children whose parents 
and guardians do not wish for their child to remain in the 
study will be handled according to local hospital policies, 
and the data will not be available for analysis.
randomisation
A computer-based randomisation will be used to assign 
patients in a 1:1 ratio using variable block sizes. The 
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allocation will be stratified by age (<1, 1–7 and >7 years), 
by level of the intended first operator seniority (junior 
and senior medical officer) and per site (hospital and 
ED or ICU). Sequentially numbered sealed opaque enve-
lopes containing patient case report forms (CRFs) will 
be provided to sites and indicate the allocated treatment 
arm when opened. Randomisation will be undertaken by 
the enrolling clinician once the operator for the proce-
dure has been determined by selecting the next number 
study pack.
Intervention
The definition of the different phases of intubation is 
pertinent for the precision of the data capture and accu-
racy of the primary outcome (figure 1).
Preoxygenation phase
The preoxygenation phase is defined as the period in 
preparation for intubation where oxygen is delivered 
to the patient to maximise oxygen concentration in the 
functional residual capacity of the lung. For the purposes 
of this study, preoxygenation can be delivered by any 
method, including nasal high flow (NHF), at the discre-
tion of the treating clinician. Preoxygenation should be 
provided with a high fraction of inspired oxygen (FiO2) 
for at least 3 min where possible. Where preoxygenation 
with high FiO2 is contraindicated or considered not 
appropriate for the patient by the treating clinician (eg, 
single ventricle physiology, unbalanced circulations), 
the FiO2 applied during the apnoeic phase should be 
the same as the FiO2 used during preoxygenation. The 
method used, FiO2 and duration of preoxygenation will 
be collected and reported.
Apnoeic oxygenation phase
The apnoeic phase begins at onset of muscle paralysis for 
rapid sequence induction leading to apnoea, or at the 
time when preoxygenation and/or non-invasive ventila-
tion are stopped for the purpose of inserting the ETT. 
For the purposes of this study, the apnoeic phase will be 
defined as commencing at the time that the mask (or 
nasal prongs) used for preoxygenation or pre-intubation 
non-invasive ventilation (eg, by bag and mask) is removed 
from the face. This correlates approximately with the 
time of onset of paralysis or the initiation of the intuba-
tion attempt if assisted ventilation is required prior to 
intubation. The study intervention will be applied at the 
onset of this period.
treatment arms
Patients will be randomised to receive either of the 
following:
1. Control: No apnoeic oxygenation or
2. THRIVE: apnoeic oxygenation with NHF.
Control
Children randomised to the standard care treatment 
arm will be intubated as per site-specific procedures/
guidelines at clinician preference. At the onset of the 
apnoeic phase, as defined above, all oxygen sources 
must be removed from the patient during the intubation 
attempted.
THRIVE intervention
Patients in the THRIVE treatment arm will be provided 
NHF oxygen rates as per table 2, with an FiO2 of 1.0 using 
an Optiflow THRIVE system (Fisher and Paykel Health-
care, Auckland, New Zealand). The flow rates selected 
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
1. Aged less than 16 years at the time of randomisation and 1. Planned endotracheal tube changes or
2. Intention for a primary nasal intubation or
2. Requires emergency intubation and ventilation in the ED or 
PICU and
3. Intubation is required immediately for loss of cardiac output 
or respiratory arrest or
3. Consent can be obtained from a parent or legal guardian 
(prospectively or delayed)
4. Location of intubation is outside ED or ICU or
5. Presence of blocked nasal airway due to anatomical 
abnormalities or
6. Blocked nasal airway due to acute injury, trauma or disease
ED, emergency department; ICU, intensive care unit; PICU, paediatric intensive care unit.
Figure 1 The phases of intubation are clearly defined 
in the protocol to ensure the intervention is applied at a 
standardised phase of the intubation procedure. The study 
allows for any method and duration of preoxygenation 
as per clinician standard practice, with details of 
preoxygenation technique and duration recorded. At the 
start of the intubation attempt (removal of the mask used 
for preoxygenation or insertion of laryngoscope blade), the 
intervention is applied. In the control group, all sources of 
apnoeic oxygen are removed at the start of intubation.
 o
n
 21 February 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-025997 on 20 February 2019. Downloaded from 
4 George S, et al. BMJ Open 2019;9:e025997. doi:10.1136/bmjopen-2018-025997
Open access 
are consistent with previously published flow rates and 
have demonstrated an increase in safe apnoea time in 
children undergoing elective intubation.7
Where preoxygenation with 100% oxygenation is 
contraindicated or considered not appropriate for the 
patient by the treating clinician (eg, single ventricle phys-
iology, unbalanced circulations), the FiO2 applied during 
the apnoeic phase should be the same as the FiO2 used 
during preoxygenation. THRIVE is to be applied immedi-
ately when the mask for preoxygenation is removed from 
the face and will be maintained throughout the apnoeic 
period and during intubation attempts. Where NHF is 
used as a preoxygenation technique, it can remain in 
place for the intervention group, ensuring that the FiO2 
is 100%, or the FiO2 is documented on the CRF in cases 
where high oxygen concentrations are contraindicated. 
THRIVE nasal prongs may be removed if rescue bag mask 
ventilation is required due to desaturation. The prongs 
will be removed on confirmation of successful ETT.
study outcomes
The clinically relevant and patient-centred outcome 
measures for intubation are hypoxemia and the number 
of attempts for a successful intubation, both of which are 
strongly interlinked.14 15 Therefore, the primary outcomes 
for this study are defined as follows:
1. hypoxemic event (patient-dependent variable) and
2. successful first attempt intubation (operator-depen-
dent variable).
Hypoxemia is defined as transcutaneous oxygen satu-
rations (SpO2) of ≤90% or a SpO2 saturation differ-
ence ≥10% for patients with cyanotic congenital heart 
disease with known substantial right-to-left shunts meas-
ured with the bedside monitor and with an accurate 
quality of the trace within the period from first insertion 
of laryngoscope until 2 min after successful and final ETT 
placement (figure 2).14 16
A successful first attempt intubation is defined as a 
successful intubation at first attempt without any hypox-
emia (SpO2 ≤90% or saturation difference ≥10% for 
right-to-left shunt). An unsuccessful intubation is either a 
successful first attempt intubation associated with hypox-
emia or requirement for any multiple (>1) intubation 
attempts.
Intubation attempt is defined as a single advanced airway 
manoeuvre beginning with the insertion of the laryngo-
scope into the child’s mouth and ending when the laryn-
goscope is removed from the child’s mouth,17 or where 
there is a change in operator during the procedure even 
if the device is not removed.
Intubation attempt with rescue oxygenation is defined as a 
period with at least one unsuccessful intubation attempt 
followed by rescue positive pressure bag mask ventilation.
secondary outcomes
(1) Number of intubation attempts and intubation attempts 
with rescue oxygenation, (2) lowest oxygen saturations 
during each attempt and throughout total intubation period, 
(3) length of mechanical ventilation, (4) ventilation free 
days (VFD, defined as the duration of respiratory support 
for all episodes with an ETT in situ for the first 28 days after 
randomisation censored at 28 days); VFD will be recorded 
as 0 in patients that died within 28 days after randomisation, 
(5) length of ICU stay in days, (6) length of hospital stay in 
days, (7) occurrence of minor AEs defined as one of the 
following in the period starting at the commencement of the 
Table 2 THRIVE flow rate regimen
Weight (kg) THRIVE flow rates
0–12 2 L/kg/min
13–15 30 L/min
16–30 35 L/min
31–50 40 L/min
>50 50 L/min
THRIVE, transnasal humidified rapid-insufflation ventilatory 
exchange.
Figure 2 In this study, the intubation period is defined as the start of intubation from removal of the mask used for 
preoxygenation and/or insertion of the laryngoscope blade and ends with successful intubation or abandonment of the attempt. 
Data collection continues for 5 min after intubation. The period from the start in intubation until 2 min after intubation is defined 
as the peri-intubation period and the period from 2 to 5 min defined as the post-intubation period. ETT, endotracheal tube.
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intubation attempt until 2 min after intubation: bradycardia, 
not requiring treatment; hypotension, not requiring treat-
ment; main stem bronchial intubation; oesophageal intuba-
tion with immediate recognition; emesis without aspiration; 
epistaxis; dental or lip trauma, (8) occurrence of major AEs 
(MAEs) defined as one of the following in the period starting 
at the commencement of the intubation attempt until 
2 min after intubation: cardiac arrest with or without return 
of spontaneous circulation; oesophageal intubation with 
delayed recognition (>60 s); emesis with aspiration; hypoten-
sion requiring treatment; bradycardia requiring treatment; 
laryngospasm; malignant hyperthermia; pneumothorax or 
pneumomediastinum1 17 and (9) death defined as death 
during current hospital admission.
All relevant study data during the study intervention will be 
recorded directly onto research data form and captured 
with video recording of the intubation attempt and for 
5-min post-ETT insertion (figure 2): (1) observations 
prior to first intubation attempt: this includes heart rate, 
oxygen saturations, blood pressure (this data is routinely 
recorded), (2) operator level of person performing 
intubation (senior: Consultant or equivalent or junior: 
Registrar), (3) specialty/discipline of person performing 
intubation, (4) intubation technique and devices used 
(direct, video, stylet, bougie, etc), (5) laryngeal view, 
grade, (6) lowest oxygen saturation during any attempt, 
(7) lowest blood pressure during any attempt, (8) highest 
and lowest pulse rate during attempt, (9) time taken for 
intubation attempt, (10) time of successful intubation 
or abandoned attempt, (11) observations immediately 
following successful intubation, (12) end tidal CO2 imme-
diately after intubation (if available) and (13) minor 
AEs and MAEs. Additional data include (but not limited): 
length of mechanical ventilation, length of ICU stay and 
length of hospital stay.
One of the research, ED or ICU nurses will be allocated 
to undertake the data collection during the procedure; 
this will usually be the nurse allocated to be the ‘scribe’ 
for the procedure. In addition, a video recording of the 
intubation will be collected to allow validation of recorded 
data and collection of missing data.
Video of intubation procedure
To maximise the quality of the data collected during a 
stressful procedure, the entire intubation procedure will 
be captured by video recording. A video recording device 
will be provided to all investigating sites. The device will 
be placed in a location to have a clear view of the intu-
bating clinician and child’s face as well as the child’s 
bedside monitor to ensure accurate observations are 
recorded during the procedure. Video will be analysed 
for a period of 5 min after successful intubation screening 
for delayed AEs. The use of the video has been extensively 
tested in the feasibility study and has not been perceived 
by nursing nor medical staff as intrusive.
Data recorded on paper CRFs will be verified against the 
video recording and corrections made where errors are iden-
tified by local research staff. Where there is a discrepancy 
between manually recorded data and video data, the video 
collected data will be used for analysis. Local research staff 
will be responsible for viewing the video and validating/
collecting the required data for the CRF. Ten per cent of 
the videos will be centrally reviewed for accuracy of data 
collection. If a discrepancy is identified in the outcome 
measures at a site, all videos from that site will be reviewed. 
Video recordings of children that are consented to partic-
ipate in the study constitute research records and as such 
will be stored on a password protected, encrypted storage 
device at the local site for 5 years after the study is closed 
and then destroyed. Video recordings of children that are 
not consented due to refusal or death prior to consent will 
form part of the child’s hospital record and will be required 
to be stored under the usual legal guidelines for paediatric 
records at that institution.
sample size
In 2016, we audited 30 children undergoing intubation in 
Queensland Children’s Hospital ED, of which 12 (40%) 
needed a second or third attempt of intubation and 50% 
experienced an AE such as hypoxemia (10%), hypotension 
(8%), ETT misplacement (21%) and other (11%). Data 
obtained from 140 intubations in PICU showed similar 
results with 30% requiring more than one attempt. This 
proportion of the hypoxemia primary outcome occurrence 
and AEs in our own audit data is comparable to a recent 
publication reporting emergency intubation in the USA.1 
In this setting, the authors described that in 1256 chil-
dren undergoing emergency intubation, 16% of children 
experienced a desaturation to less than 80% during the 
first attempt of intubation and on average 40% required a 
second attempt at least. In this paper, the authors describe 
per age group a very similar distribution of failed attempts, 
with age groups defined <1, 1–7 and >7 years. A conserva-
tive estimate of the primary outcome of hypoxemia is set 
at 16%. We assume 90% power to detect a 50% reduction 
of desaturation events (hypoxia) from 16% to 8% and an 
alpha of 0.025 (Bonferroni’s correction for two primary 
outcomes), resulting in 816 participants required. For our 
other primary outcome, successful first attempt intubation, 
we estimate an increase from 60% to 80%; with 90% power 
and an alpha of 0.025, 258 participants are required. There-
fore, an overall total sample of 960 children is required 
including 15% attrition which satisfies the sample size 
requirements for both outcomes.
statistical analysis plan
Descriptive statistics will be utilised to report on the base-
line characteristics of the total study cohort and each 
subgroup, as well as by site. The primary and secondary 
outcome measures investigating binary clinical outcomes 
will be compared using a χ2 test, and the difference 
between treatment groups will be reported as the risk 
difference, 95% CI and p value. For continuous outcomes, 
it will first be determined whether the data are normally 
distributed; if so, a t-test will be used for comparison, 
otherwise, a Mann-Whitney U test will be used. Analysis 
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will be by intention-to-treat. Statistical significance will 
be set at the 0.025 level for primary outcomes, and 0.05 
for other comparisons. Post-hoc power analyses may 
be undertaken to determine whether results found in 
subgroup analyses are reliable particularly for age groups 
(<1, 1–7 and >7 years). A preplanned secondary analysis 
of the outcome data will be reported for children with 
SpO2 <80% during intubation.
health economics evaluation
We will undertake ex-post within-trial modelling to deter-
mine the cost-effectiveness of the intervention compared 
with standard care, using a cost-effectiveness approach. 
Unit costs will be extracted from standard sources. A stan-
dard within-trial cost utility analysis will be undertaken 
under the horizon of 28 days. This will compare costs 
and benefits in terms of resource use related to the inter-
vention and other care and length of stay in both PICU 
and non-intensive care. Estimates of mean costs and CIs 
will be provided. Models will include sensitivity analysis. 
Resource use data will be collected for trial participants 
and the collated unit costs will be assigned to the resource 
utilisation to provide overall costs for both arms of the 
trial. The analysis will be from the healthcare provider 
perspective. The New Zealand country healthcare costs 
will be analysed separately and findings from different 
systems will be compared.
Ethics and dissemination
One of the primary challenges in performing research 
in an emergency setting is the inability to obtain true 
informed consent. Frequently, parents and guardians are 
not initially available when their child is brought into the 
ED. Furthermore, when parents or guardians are present, 
they are often too distressed by the situation to compre-
hend study procedures and there is not enough time to 
obtain informed consent.18–20
In all participating centres, prospective consent will be 
obtained from the parent or guardian where possible. 
When prospective consent is not possible or practical, and 
local legislation allows, patients will be randomised to the 
study and written informed consent to remain in the study 
will be sought from parents and guardians at the earliest 
possible time after emergency stabilisation of the child 
(consent-to-continue). Data for children whose parents 
and guardians do not wish for their child to remain in the 
study will be handled according to local hospital policies, 
and the data will not be available for analysis.
This study has ethical approval for consent-to-continue 
(deferred consent) for participating Australian sites. For 
sites in New Zealand, approval has been received for 
prospective consent only due to local regulatory require-
ments. The method of consent will be presented for all 
enrolled patients, along with summary data for patients 
eligible but not enrolled.
Results from the study will be submitted to a peer-reviewed 
journal for publication and for presentation at national and 
international conferences. Once the outcomes are known, 
targeted knowledge translation activities will be developed 
and work to incorporate the results into airway manage-
ment guidelines will be undertaken.
Patient and public involvement
During the development of the protocol, parents of 
children being intubated were interviewed regarding 
the acceptability of research participation during a 
time-critical procedure and the acceptability of video 
recording during the procedure. Parents were supportive 
of research in these situations, and also reported no 
concerns regarding the use of video recording during 
the procedure. Participants are asked if they would like 
to receive a copy of the outcomes of the study during the 
consent process and an email address is collected to facil-
itate distribution of any relevant publications.
time frame
It is anticipated that a 3-year recruitment period is needed 
to achieve the required sample size.
Adverse events and monitoring/reporting
The Data and Safety Monitoring Board (DSMB) consists 
of an anaesthetist, a paediatric intensivist and a statistician. 
None of the DSMB members will be involved in recruit-
ment of study patients at their site. DSMB members will 
not be supervised by any study investigator, or participate 
as investigators in any study currently under review by this 
DSMB. The primary objective of the DSMB is to monitor 
the safety of the intervention and the validity and integ-
rity of the data from the Kids THRIVE study. Addition-
ally, the DSMB will evaluate the pace of recruitment and 
will make recommendations to the Kids THRIVE Chief 
Investigator(s) and Steering Board regarding the contin-
uation, modification or termination of the study.
AE data are collected as part of the study design and 
form the primary and secondary outcomes of the study. 
Conditions that are present at screening and do not dete-
riorate will not be considered AEs. Patients participating 
in this trial are critically ill and the reason for requiring 
the intubation is often respiratory, neurological or cardio-
vascular failure with acute risk of death. Except for death 
during or within 1 hour of intubation and oesophageal 
intubation with late recognition, AEs as listed in the 
outcome parameters are expected and according to 
current clinical practice ‘accepted’ outcomes. Hence, 
these outcomes are not routinely reported as AEs nor 
to the DSMB. However, if any of the attending clinicians 
suspect an AE that is related to the study design, such an 
AE will be reported.
Serious AEs are defined as follows:
1. Cardiac arrest or death during or within an hour of the 
intervention.
2. Oesophageal intubation with late recognition
Any serious AE will be reported to the Human Research 
Ethics Committee (HREC) within 24–72 hours of occur-
rence, in accordance with the safety reporting policy 
of the HREC. Set DSMB review points on the progress 
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and safety of the trial are predefined as after the primary 
outcome is known for 200 children.
data accuracy and integrity
Intubation and ventilation of a child in the ED and ICU 
settings represent a highly stressful event and require 
significant human resources to assemble equipment while 
effectively managing a critically unwell patient. As a result, 
attention to data collection for a research study is often 
overlooked, with the immediate needs of the patient always 
taking priority. This study is dependent on high-quality and 
accurate data at a critical moment of the patient’s manage-
ment, and the potential for missing or inaccurate data 
collection is high. It is also recognised that significant bias 
can be introduced to a study of this type when relying on 
retrospective recall of critical data values. A retrospective 
review of intubation records compared with video-recorded 
data has highlighted that there is a significant under-re-
porting of AEs, especially oxygen desaturation, and an 
over-reporting of first-attempt success rates, in the magni-
tude of 21% and 12%, respectively, when reliant on oper-
ator-/observer-reported data.21
For this reason, a video recording of the intubation 
procedure will be captured for data verification purposes 
and to protect the integrity of the primary end point. 
Where a discrepancy between the manually recorded data 
and video-recorded data exists, the video-recorded data 
will be used for analysis as it can be objectively confirmed.
Current status of trial
The study enrolment has commenced in May 2017 and 
the sites involved are as follows:
Queensland Children’s Hospital, Townsville Hospital, 
Gold Coast University Hospital, Royal Children’s Hospital 
Melbourne, Womens and Children’s Hospital Adelaide, 
Perth Childrens Hospital and Starship Children’s Hospital 
Auckland. Expansion to additional sites is planned.
sIgnIfICAnCE
This large multicentre randomised trial may help define 
the role of THRIVE during emergency intubation in 
infants and children. The intubation of a child in the 
emergency setting places a tremendous emotional strain 
on both the child and parents. Dependent on the skill 
level and experience of the clinician performing the 
procedure, the professional stress level may also be very 
high as intubation is a high-risk procedure, which needs 
to be accomplished in a timely manner. The study will 
provide high-fidelity data using video recording of the 
study interventions and the findings will easily be trans-
lated into clinical practice.
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